PTP
DARE icon

Platform Technology Partners’s Dare Bioscience DARE Stock Holding History

Platform Technology Partners’s Portfolio DARE Stock Details DARE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		$20K Buy
+1,250
New +$17.5K 0.01% 238

Other funds holding DARE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
PVMCV
Polaris Venture Management Co V Boston, Massachusetts $14.1M AUM 121.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
FFS
Founders Financial Securities Towson, Maryland $1.77B AUM 17.63% 1-Year Est. Return

Platform Technology Partners's DARE Position: Q4 2020 in Review

Platform Technology Partners opened a new position in Dare Bioscience (DARE) in Q4 2020: 1,250 shares worth $20K. The stake represents 0.01% of the portfolio and ranks #238 among its holdings.

27 funds tracked by Wall St. Rank hold DARE as of Q4 2020.

  • Platform Technology Partners held 1,250 shares of Dare Bioscience worth $20K as of Q4 2020.
  • Dare Bioscience was a new Platform Technology Partners position in Q4 2020.
  • Dare Bioscience made up 0.01% of Platform Technology Partners's portfolio in Q4 2020, its #238 holding.
  • 27 funds tracked by Wall St. Rank held Dare Bioscience as of Q4 2020.

Based on Platform Technology Partners's 13F filing for Q4 2020, filed 9 Feb 2021.